Skip to Main Content

Author Details

Susmita G Ramanand
UT Southwestern Medical Center
2010
17
11
PMIDPaper TitleJournal TitlePublished Year
35931036Stress and the CITI.Mol Cell2022
35703180FOXA2 suppresses endometrial carcinogenesis and epithelial-mesenchymal transition by regulating enhancer activity.J Clin Invest2022
36108240Prostate Cancer Transcriptomic Regulation by the Interplay of Germline Risk Alleles, Somatic Mutations, and 3D Genomic Architecture.Cancer Discov2022
34107419Disruptin, a cell-penetrating peptide degrader of EGFR: Cell-Penetrating Peptide in Cancer Therapy.Transl Oncol2021
32343676The landscape of RNA polymerase II-associated chromatin interactions in prostate cancer.J Clin Invest2020
31591588Genome-wide germline correlates of the epigenetic landscape of prostate cancer.Nat Med2019
31900904Genetic, Environmental, and Nuclear Factors Governing Genomic Rearrangements.Adv Exp Med Biol2019
29346775BRD4 Promotes DNA Repair and Mediates the Formation of TMPRSS2-ERG Gene Rearrangements in Prostate Cancer.Cell Rep2018
28754673Androgen Receptor Variants Mediate DNA Repair after Prostate Cancer Irradiation.Cancer Res2017
27926866Inflammation-Induced Oxidative Stress Mediates Gene Fusion Formation in Prostate Cancer.Cell Rep2016
24709418Efficacy of an EGFR-specific peptide against EGFR-dependent cancer cell lines and tumor xenografts.Neoplasia2014
22907806Effect of erlotinib on epidermal growth factor receptor and downstream signaling in oral cavity squamous cell carcinoma.Head Neck2013
23897823Destabilization of the epidermal growth factor receptor (EGFR) by a peptide that inhibits EGFR binding to heat shock protein 90 and receptor dimerization.J Biol Chem2013
23468959Tristetraprolin mediates radiation-induced TNF-α production in lung macrophages.PLoS One2013
22952420Wild-type EGFR is stabilized by direct interaction with HSP90 in cancer cells and tumors.Neoplasia2012
21750205Early tumor progression associated with enhanced EGFR signaling with bortezomib, cetuximab, and radiotherapy for head and neck cancer.Clin Cancer Res2011
20215522Role of epidermal growth factor receptor degradation in cisplatin-induced cytotoxicity in head and neck cancer.Cancer Res2010
  • 1 - 17 of 17

Recommended Authors

Joshua Armenia
Oncology R&D
Career Start Year 2013
Number of shared co-authors 11
Haiyang Guo
the Second Hospital, Cheeloo College of Medicine, Shandong University
Career Start Year 2011
Number of shared co-authors 27
Frederick S Vizeacoumar
College of Medicine, University of Saskatchewan
Career Start Year 2010
Number of shared co-authors 1
Kasey Jividen
Center for Cell Signaling, University of Virginia
Career Start Year 2010
Number of shared co-authors 0
Anne Haegert
University of British Columbia
Career Start Year 2008
Number of shared co-authors 4
Yu Chen
School of Pharmacy, University of Wisconsin-Madison
Career Start Year 2008
Number of shared co-authors 4
David A Quigley
University of California-San Francisco
Career Start Year 2008
Number of shared co-authors 13
Robert J Lonigro
Michigan Center for Translational Pathology, University of Michigan ann arbor
Career Start Year 2007
Number of shared co-authors 10
Michael C Haffner
Fred Hutchinson Cancer Center
Career Start Year 2005
Number of shared co-authors 12
Gong-Hong Wei
Fudan University Shanghai Cancer
Career Start Year 2004
Number of shared co-authors 7
Wilbert Zwart
Oncode Institute, The Netherlands Cancer Institute
Career Start Year 2004
Number of shared co-authors 19
Scott A Tomlins
Rogel Cancer Center, University of Michigan Medical School ann arbor
Career Start Year 2003
Number of shared co-authors 14
Charlie E Massie
University of Cambridge
Career Start Year 2003
Number of shared co-authors 4
Jianmin Wang
Roswell Park Comprehensive Cancer Center
Career Start Year 2003
Number of shared co-authors 0
Xiaohu Zhang
National Center for Advancing Translational Sciences
Career Start Year 2003
Number of shared co-authors 0
Ladan Fazli
University of British Columbia
Career Start Year 2002
Number of shared co-authors 13
Luke A Selth
Adelaide Medical School, University of Adelaide
Career Start Year 2002
Number of shared co-authors 5
Sooryanarayana Varambally
University of Alabama at Birmingham, USA O'Neal Comprehensive Cancer Center
Career Start Year 2001
Number of shared co-authors 5
David S Rickman
Meyer Cancer Center
Career Start Year 2001
Number of shared co-authors 2
Srinivasan Yegnasubramanian
Johns Hopkins University School of Medicine
Career Start Year 1999
Number of shared co-authors 3
Eddy S Yang
University of Alabama at Birmingham, O'Neal Comprehensive Cancer Center
Career Start Year 1999
Number of shared co-authors 2
Leena Latonen
Foundation for the Finnish Cancer Institute
Career Start Year 1999
Number of shared co-authors 0
Jun Yao
The University of Texas MD Anderson Cancer Center
Career Start Year 1997
Number of shared co-authors 0
Ian G Mills
Queen's University Belfast
Career Start Year 1997
Number of shared co-authors 6
Shiaw-Yih Lin
The University of Texas MD Anderson Cancer Center
Career Start Year 1996
Number of shared co-authors 0
Yi-Mi Wu
University of Michigan Medical School ann arbor
Career Start Year 1995
Number of shared co-authors 9
Colin C Collins
University of British Columbia
Career Start Year 1988
Number of shared co-authors 35
William C Hahn
Broad Institute of MIT and Harvard, USA Dana-Farber Cancer Institute
Career Start Year 1987
Number of shared co-authors 6
Charles L Sawyers
Memorial Sloan Kettering Cancer Center
Career Start Year 1986
Number of shared co-authors 10
Matthew Meyerson
Broad Institute
Career Start Year 1983
Number of shared co-authors 4

Collaborators

Ram S Mani
UT Southwestern Medical Center
Co-authored papers 8
Yunpeng Gao
University of Texas Southwestern Medical Center at Dallas
Co-authored papers 4
Chao Xing
University of Texas Southwestern Medical Center
Co-authored papers 4
GuemHee Baek
UT Southwestern Medical Center
Co-authored papers 4
Ganesh V Raj
University of Texas Southwestern Medical Center at Dallas
Co-authored papers 3
Adam Aslam
Wayne State University/Detroit Medical Center
Co-authored papers 3
Paul C Boutros
University of California los angeles
Co-authored papers 3
Johann S de Bono
The Institute for Cancer Research
Co-authored papers 3
Kathleen E Houlahan
University of California los angeles
Co-authored papers 3
Mohammed Kanchwala
The University of Texas Southwestern Medical Center
Co-authored papers 3
Jiapei Yuan
UT Southwestern Medical Center
Co-authored papers 3
Yong Chen
Rowan University
Co-authored papers 2
Carter Van Waes
National Institute of Deafness and Other Communication Disorders
Co-authored papers 2
Michael Q Zhang
The University of Texas at Dallas
Co-authored papers 2
Wei Yuan
The Institute for Cancer Research
Co-authored papers 2
Adam Sharp
The Institute for Cancer Research
Co-authored papers 2
Yu-Jia Shiah
Ontario Institute for Cancer Research
Co-authored papers 1
Ingrid L Bergin
University of Michigan ann arbor
Co-authored papers 1
Michael Fraser
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 1
Housheng Hansen He
Princess Margaret Cancer Center, University Health Network, University of Toronto
Co-authored papers 1
Cindy Q Yao
Ontario Institute for Cancer Research
Co-authored papers 1
Minyoung Jang
Columbia University Irving Medical Center
Co-authored papers 1
Suzanne Carreira
The Institute of Cancer Research
Co-authored papers 1
Zhong Chen
National Institute on Deafness and Other Communication Disorders
Co-authored papers 1
Bernard T??tu
Centre de Recherche du CHU de Quebec-Universite Laval (axe Oncologie)
Co-authored papers 1
Xuhong Cao
Michigan Center for Translational Pathology.
Co-authored papers 1
Robert G Bristow
University of Toronto
Co-authored papers 1
Lawrence E Heisler
Ontario Institute for Cancer Research
Co-authored papers 1
Ada Wong
University Health Network
Co-authored papers 1
Maryou B Lambros
The Institute of Cancer Research
Co-authored papers 1
Release 1.2